NASDAQ:TRHC - Tabula Rasa HealthCare Stock Price, Forecast & News

Tabula Rasa HealthCare trades on the NASDAQ under the ticker symbol "TRHC."

Tabula Rasa HealthCare Inc (NASDAQ:TRHC) announced its quarterly earnings results on Thursday, November, 7th. The company reported ($0.06) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.07) by $0.01. The business earned $74.27 million during the quarter, compared to the consensus estimate of $75.37 million. Tabula Rasa HealthCare had a positive return on equity of 0.50% and a negative net margin of 13.46%. View Tabula Rasa HealthCare's Earnings History.

Tabula Rasa HealthCare is scheduled to release their next quarterly earnings announcement on Thursday, February 27th 2020. View Earnings Estimates for Tabula Rasa HealthCare.

Tabula Rasa HealthCare issued an update on its FY 2019 After-Hours earnings guidance on Monday, November, 25th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $$282-285 million, compared to the consensus revenue estimate of $$289.21 million.

7 brokerages have issued 12 month target prices for Tabula Rasa HealthCare's stock. Their forecasts range from $50.00 to $88.00. On average, they anticipate Tabula Rasa HealthCare's stock price to reach $68.62 in the next year. This suggests a possible upside of 25.0% from the stock's current price. View Analyst Price Targets for Tabula Rasa HealthCare.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last year. There are currently 2 hold ratings, 4 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Tabula Rasa HealthCare.

Press coverage about TRHC stock has trended somewhat positive this week, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Tabula Rasa HealthCare earned a news sentiment score of 1.7 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the near future. View News Stories for Tabula Rasa HealthCare.

Tabula Rasa HealthCare saw a increase in short interest in December. As of December 31st, there was short interest totalling 7,360,000 shares, an increase of 9.4% from the December 15th total of 6,730,000 shares. Based on an average trading volume of 319,800 shares, the days-to-cover ratio is currently 23.0 days. Approximately 36.5% of the shares of the stock are sold short. View Tabula Rasa HealthCare's Current Options Chain.

Some companies that are related to Tabula Rasa HealthCare include MAXIMUS (MMS), Ritchie Bros. Auctioneers (RBA), CIELO S A/S (CIOXY), TriNet Group (TNET), Farfetch (FTCH), Envestnet (ENV), WNS (WNS), Sothebys (BID), HMS (HMSY), ExlService (EXLS), EVO Payments (EVOP), Cardtronics (CATM), Wageworks (WAGE), GreenSky (GSKY) and Stamps.com (STMP).

Based on aggregate information from My MarketBeat watchlists, some companies that other Tabula Rasa HealthCare investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Canopy Growth (CGC), Adobe (ADBE), Netflix (NFLX), QUALCOMM (QCOM), VMware (VMW), Micron Technology (MU), salesforce.com (CRM) and Paypal (PYPL).

(TRHC) raised $60 million in an initial public offering on Thursday, September 29th 2016. The company issued 4,300,000 shares at $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray acted as the underwriters for the IPO and Baird and Stifel were co-managers.

Tabula Rasa HealthCare's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Peregrine Capital Management LLC (1.51%), Artemis Investment Management LLP (1.26%), Summit Creek Advisors LLC (1.02%), Mirador Capital Partners LP (0.24%), State of Alaska Department of Revenue (0.07%) and Louisiana State Employees Retirement System (0.03%). Company insiders that own Tabula Rasa HealthCare stock include Andrea Carolan Speers, Brian W Adams, Bruce Luehrs, Calvin H Knowlton, Dennis Helling, Gordon Tunstall, Orsula V Knowlton and Samira Beckwith. View Institutional Ownership Trends for Tabula Rasa HealthCare.

TRHC stock was sold by a variety of institutional investors in the last quarter, including Louisiana State Employees Retirement System and State of Alaska Department of Revenue. Company insiders that have sold Tabula Rasa HealthCare company stock in the last year include Andrea Carolan Speers, Brian W Adams, Calvin H Knowlton, Dennis Helling, Gordon Tunstall and Orsula V Knowlton. View Insider Buying and Selling for Tabula Rasa HealthCare.

TRHC stock was bought by a variety of institutional investors in the last quarter, including Summit Creek Advisors LLC, Artemis Investment Management LLP, Peregrine Capital Management LLC and Mirador Capital Partners LP. View Insider Buying and Selling for Tabula Rasa HealthCare.

Shares of TRHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of TRHC stock can currently be purchased for approximately $54.88.

Tabula Rasa HealthCare has a market capitalization of $1.22 billion and generates $204.27 million in revenue each year. The company earns $-47,270,000.00 in net income (profit) each year or $0.34 on an earnings per share basis. Tabula Rasa HealthCare employs 952 workers across the globe.View Additional Information About Tabula Rasa HealthCare.

The official website for Tabula Rasa HealthCare is http://www.tabularasahealthcare.com/.

Tabula Rasa HealthCare's mailing address is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. The company can be reached via phone at 866-648-2767 or via email at [email protected]